Late-breaking Abstract at ASH Supports Evidence on Transformative First-ever Treatment in Primary HLH
SWEDISH ORPHAN ADR (SWTUY)
NASDAQ:AMEX Investor Relations:
sobi.com/en/investors-and-media
Company Research
Source: PR Newswire
STOCKHOLM, Nov. 22, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) and Novimmune SA are pleased to announce that the abstract "Safety and efficacy of emapalumab in paediatric patients with primary hemophagocytic lymphohistiocytosis" was accepted as a late-breaking abstract at the 60th Annual Meeting of the American Society of Hematology in San Diego, California, 1-4 December 2018, for oral presentation. The presentation of the data will be given on Tuesday, 4 December, by the first author Professor Franco Locatelli, Head of the Department of Onco-Haematology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. Late-breaking abstracts highlight novel and substantive studies of high impact.Emapalumab is an interferon gamma (IFN?) blocking antibody which has just been approved under the trade name Gamifant® by the FDA in the US for the treatment of paediatric (newborn and older) and adult patients with primary haemophagocytic lymphohistiocytosis (HLH) with refractory, r
Show less
Read more
Impact Snapshot
Event Time:
SWTUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWTUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWTUY alerts
High impacting SWEDISH ORPHAN ADR news events
Weekly update
A roundup of the hottest topics